Neil E. Stahl - 07 Feb 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Signature
/s/**Neil E. Stahl
Issuer symbol
REGN
Transactions as of
07 Feb 2024
Net transactions value
-$7,637,954
Form type
4
Filing time
08 Feb 2024, 16:02:33 UTC
Previous filing
06 Feb 2024
Next filing
28 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale $94,734 -100 -0.17% $947.34 59,956 07 Feb 2024 Direct
transaction REGN Common Stock Sale $1,796,819 -1,894 -3.2% $948.69 58,062 07 Feb 2024 Direct F1
transaction REGN Common Stock Sale $570,619 -601 -1% $949.45 57,461 07 Feb 2024 Direct F2
transaction REGN Common Stock Sale $2,971,995 -3,127 -5.4% $950.43 54,334 07 Feb 2024 Direct F3
transaction REGN Common Stock Sale $1,176,993 -1,237 -2.3% $951.49 53,097 07 Feb 2024 Direct F4
transaction REGN Common Stock Sale $1,008,687 -1,059 -2% $952.49 52,038 07 Feb 2024 Direct F5
transaction REGN Common Stock Sale $18,107 -19 -0.04% $953.00 52,019 07 Feb 2024 Direct
holding REGN Common Stock 5,834 07 Feb 2024 By 401(k) Plan
holding REGN Common Stock 4,605 07 Feb 2024 by Spouse as Trustee
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents volume-weighted average price of sales of 1,894 shares of Company stock on February 7, 2024 at prices ranging from $948.19 to $948.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2024 at each separate price.
F2 Represents volume-weighted average price of sales of 601 shares of Company stock on February 7, 2024 at prices ranging from $949.22 to $949.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2024 at each separate price.
F3 Represents volume-weighted average price of sales of 3,127 shares of Company stock on February 7, 2024 at prices ranging from $950.00 to $950.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2024 at each separate price.
F4 Represents volume-weighted average price of sales of 1,237 shares of Company stock on February 7, 2024 at prices ranging from $951.00 to $951.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2024 at each separate price.
F5 Represents volume-weighted average price of sales of 1,059 shares of Company stock on February 7, 2024 at prices ranging from $952.03 to $952.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2024 at each separate price.